Stocktoria

RadNet, Inc. RDNT

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2001-12-12 · LEI

RadNet, Inc. financials (annual)

Revenue
$884.5M $922.2M $975.1M $1.15B $1.07B $1.32B $1.43B $1.62B $1.83B $2.04B 2016201720182019202020212022202320242025
Net income
$7.2M $53000 $32.2M $14.8M -$14.8M $24.7M $10.7M $3.0M $2.8M -$18.7M 2016201720182019202020212022202320242025
Free cash flow
$32.4M $80.9M $44.6M $30.2M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$2.0B$1.8B$1.6B$1.4B$1.3B$1.1B$1.2B$975.1M$922.2M$884.5M
Operating income$62.0M$104.6M$98.7M$46.4M$82.6M$35.7M$69.9M$30.9M$50.0M$38.5M
Income tax$14.9M$6.0M$8.5M$9.4M$14.6M$895,000$6.2M$394,000$24.3M$4.4M
Net income-$18.7M$2.8M$3.0M$10.7M$24.7M-$14.8M$14.8M$32.2M$53,000$7.2M
EPS (diluted)$-0.25$0.04$0.05$0.17$0.46$-0.29$0.29$0.66$0.00$0.15
Operating cash flow$298.8M$233.0M$220.9M$146.4M$149.5M$233.8M$104.3M$116.8M$142.2M$91.6M
Free cash flow$30.2M$44.6M$80.9M$32.4M
Cash & equivalents$767.2M$740.0M$342.6M$127.8M$134.6M$102.0M$40.2M$10.4M$51.3M$20.6M
Total assets$3.8B$3.3B$2.7B$2.4B$2.1B$1.8B$1.6B$1.1B$869.0M$849.5M
Total liabilities$2.4B$2.2B$1.9B$1.9B$1.7B$1.5B$1.4B$909.1M$799.1M$797.4M
Shareholders' equity$1.4B$1.1B$813.4M$491.5M$346.2M$258.3M$233.1M$200.3M$69.9M$52.1M

Growth · year-over-year · Revenue CAGR 9.7%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+11.5%+13.2%+13.0%+8.7%+22.7%-7.1%+18.4%+5.7%+4.3%+9.3%
Net income growth-767.8%-8.2%-71.4%-56.9%-200.6%-54.2%+60735.8%-99.3%-6.2%
EPS growth-725.0%-20.0%-70.6%-63.0%-200.0%-56.1%-100.0%-11.8%
Free cash flow growth-32.3%-44.9%+149.7%+34.5%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.